Conjugated linoleic acid (CLA)-producing probiotics are significant in metabolic diseases; therefore, the probiotic-to-functional attributes of six potential antiobesity and anti-inflammatory CLA isomer-producing lactobacilli isolated from infant stools were analyzed. Lactobacillus fermentum DDHI27 and La. plantarum DDHI128 were tolerated well at pH 1.5 with fewer log reductions, whereas in bile, except for La. plantarum DDHI191, all thrived well. Also, these strains have better bile salt deconjugation activity. Higher scavenging activities were noticed for these strains with 2,2′-azino-bis(3-ethylbenzothiazoline-6-sulfonic acid radicals compared with 1,1-diphenyl-2-picrylhydrazyl, although DDHI27 and DDHI191 strains were observed as having the most antioxidative activity. Antimicrobial screening revealed that DDHI27 was the most dominating antagonist followed by DDHI128 and DDHI15 strains. These strains were susceptible to most of therapeutic antibiotics except for few and this was correlated with their internal natural phenomenon. Finally, in adhesion assay maximum adherence to Caco-2 cells was noticed with DDHI27. Hence, DDHI27 could be exploited as a source of dietary CLA supplementation.
PRACTICAL APPLICATIONSThe screened strain have good probiotic and functional attributes; therefore, it might increase the probiotic diversity in food industry for functional food formulation, especially those that help in managing lifestyle and other diseases. These foods are also the need of the hour, as the majority of available pharmaceutical drugs in market are inefficient and poised adverse effects on the health of the consumer. Additionally, selected strain might be a suitable candidate for gut microbial ecological studies in diseased conditions, as it has shown good antimicrobial and cell adherence ability that might be helpful in replacing the disrupted gut microbiota (responsible for the onset of various metabolic diseases) via competitive exclusion.